Kneat.com, Inc.

TSX:KSI.TO

Medical - Healthcare Information Services

Healthcare
$6.50 -0.16%

-$0.01 today

Market cap
$624.86M
Beta
1.37
P/E (TTM)
-73.0
EPS (TTM)
-$0.09
52W Low $3.23High $6.44

Volume 0.10M

Average 0.31M

KSI.TO Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Kneat.com, Inc.TSX: KSI.TO

Gross Profit · Q1 FY2026 · quarter ended Mar 2026

Gross profit dips below year-ago levels

Q1 FY2026 gross profit of CA$10.21M fell 6.6% year over year, behind the +0.6% change in trailing-twelve-month gross profit. Sequentially, it rose 10.6% from the prior quarter. Over 3 fiscal years it compounded at +33.3% a year.

Context

  • Gross profit amounted to 54.9% of revenue in FY2025, down 20.3 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -6.6% toward the trailing-twelve-month pace of +0.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$10.21M+10.6% QoQ
Last fiscal yearDec 2025
CA$34.7M-5.6% YoY
LTMMar 2026
CA$39.98M+0.6% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-6.6%——
1 year-5.6%——
3-year CAGR+33.3%——
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2025
34.7M CAD
Year-over-year change
-5.6%
4-year CAGR
+38.9%

Gross Profit vs competitors

How KSI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +0.6% is the 4th highest of 7, against a peer median of +3.1%.
  • Gross profit amounts to 60.1% of revenue for KSI.TO, versus a peer median of 55.9%.
KSI.TO Competitors
Gross Profit for KSI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$190.52M CAD+13.7%+3.0%37.3%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$100.28M CAD-46.5%—31.5%
VHI.TOVitalhub Corp.LTM Mar 2026CA$89.15M CAD+47.0%+32.4%74.8%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$73.53M CAD-7.5%—23.6%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$39.98M CAD+0.6%+33.3%60.1%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$37.95M USD+33.5%+26.5%74.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$2.19M CAD-303.3%—79.2%
Peer median (excluding KSI.TO) —+3.1%+26.5%55.9%

Competitors are the stored peer set for KSI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue15.5M23.75M34.22M48.94M63.26M
Cost of Revenue6.18M9.09M11.09M12.18M28.56M
Gross Profit9.32M14.65M23.13M36.76M34.7M
Gross Margin60.1%61.7%67.6%75.1%54.9%
Research & Development8.33M10.99M15.76M17.27M8.84M
Selling, General & Admin7.35M13.44M20.98M25.44M34.31M
Operating Expenses15.67M24.43M36.74M42.71M43.15M
Depreciation & Amortization4.44M5.7M7.61M10.13M13.99M
EBITDA(5.11M)(3.2M)(5.37M)6.27M5.54M
EBITDA Margin-33.0%-13.5%-15.7%12.8%8.8%
Operating Income(6.35M)(9.77M)(13.53M)(5.95M)(8.45M)
Operating Margin-41.0%-41.2%-39.5%-12.2%-13.4%
Interest Income6.45K2.75K6.64K678.39K516.74K
Interest Expense284.95K228.59K1.08M3.67M3.43M
Other Income / Expenses(3.48M)642.86K(529.44K)(1.59M)6.26M
Income Before Tax(9.84M)(9.13M)(14.06M)(7.53M)(2.19M)
Pre-Tax Margin-63.5%-38.5%-41.1%-15.4%-3.5%
Income Tax Expense20.91K16.61K55.89K192.6K158.86K
Net Income(9.86M)(9.15M)(14.12M)(7.73M)(2.35M)
Net Margin-63.6%-38.5%-41.3%-15.8%-3.7%
EPS (Basic)(0.13)(0.12)(0.18)(0.09)(0.02)
EPS (Diluted)(0.13)(0.12)(0.18)(0.09)(0.02)
Weighted Avg Shares74.11M77.44M77.83M86.55M94.91M
Weighted Avg Shares (Diluted)74.11M77.44M77.83M86.55M94.91M

Kneat.com, Inc.

TSX:KSI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.